English | Español
Press release submission | Apr 8, 2021

ACELRX: Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedure
Press release submission | Apr 1, 2021

SQI DIAGNOSTICS: Submits RALI-Dx™ IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
Press release submission | Mar 31, 2021

SANOFI: FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma
Press release submission | Mar 18, 2021

Pack Health and National Multiple Sclerosis Society Announce Partnership to Support Patients with MS
Press release submission | Mar 10, 2021

LINNAEUS THERAPEUTICS: Granted Orphan Drug Designation for LNS8801 for the Treatment of Patients with Metastatic Uveal Melanoma
Press release submission | Feb 25, 2021

EVERSANA: Launches Chronic Disease Real-World Data Solution Covering More Than 80 Million Deidentified Patients to Drive Regulatory-Grade Clinical Research and Improve Patient Outcomes
Press release submission | Feb 4, 2021

CDI: Commonwealth Diagnostics International, Inc.'s IBSchek® Granted PLA Code from AMA; Company to Now Accept Insurance, Providing More Patients At-Home Access
Benjamin Kibbey | Jan 7, 2021

Average U.S. life expectancy rose prior to COVID-19 pandemic

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’